{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:26Z","timestamp":1792807106293,"version":"4.5.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082694","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T16:49:20Z","timestamp":1392396560000},"page":"e82694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials"],"prefix":"10.1371","volume":"9","author":[{"given":"James M.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne R.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hywel C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2133.2006.07419.x","article-title":"Oedema as a risk factor for multiple episodes of cellulitis\/erysipelas of the lower leg: a series with community follow-up","volume":"155","author":"NH Cox","year":"2006","journal-title":"British Journal of Dermatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation","volume":"89","author":"A Jeng","year":"2010","journal-title":"Medicine"},{"key":"ref3","first-page":"779","article-title":"Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol","volume":"125","author":"P Bernard","year":"1989"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2133.2011.10275.x","article-title":"Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care","volume":"164","author":"N Levell","year":"2011","journal-title":"British Journal of Dermatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2133.2007.08423.x","article-title":"Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis","volume":"158","author":"JK Soo","year":"2008","journal-title":"British Journal of Dermatology"},{"key":"ref6","first-page":"978","article-title":"British National Formulary. Pharmaceutical Press; 59th Revised edition","volume":"ISBN-13","year":"2010"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, Nasr IS, Brindle RJ, English BS, Meredith SK, Reynolds NJ, de Berker D, Mortimer PS, Williams HC on behalf of the UK Dermatology Clinical Trials Network\u2019s PATCH I Trial Team. (2013) Penicillin to Prevent Leg Cellulitis Recurrence: randomized controlled trial. New England Journal of Medicine 368; 1695\u20131703.","DOI":"10.1056\/NEJMoa1206300"},{"key":"ref8","first-page":"169","article-title":"Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network\u2019s PATCH II trial. Br J Dermatol","volume":"166","year":"2012"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-4453(91)90898-3","article-title":"Long-term antimicrobial therapy in the prevention of recurrent sort-tissue infections","volume":"122","author":"M Kremer","year":"1991","journal-title":"Journal of Infection"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01728920","article-title":"Antibiotic prophylaxis in recurrent erysipelas","volume":"21","author":"AC Sjoblom","year":"1993","journal-title":"Infection"},{"key":"ref11","first-page":"894","article-title":"Benzathine penicillin prophylaxis in recurrent erysipelas","volume":"24","author":"M Chakroun","year":"1994","journal-title":"Mal Med Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/014107689809101206","article-title":"Management and morbidity of cellulitis of the leg","volume":"91","author":"NH Cox","year":"1998","journal-title":"Journal of the Royal Society of Medicine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01650206","article-title":"Recurrent erysipelas: predisposing factors and costs of prophylaxis","volume":"15","author":"C Jorup-Ronstrom","year":"1987","journal-title":"Infection"},{"key":"ref14","unstructured":"Hospital Episode Statistics. (2011) HESOnline: Inpatient data, primary diagnosis (4 character). http:\/\/www.hesonline.nhs.uk\/(last<\/ext-link> accessed 28\u20133-2013)."},{"key":"ref15","unstructured":"Curtis L. (2012) Unit Costs of Health and Social Care 2011, University of Kent http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2011\/index.php<\/ext-link>; last accessed 28\u20133-2013."},{"key":"ref16","first-page":"834","article-title":"Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol","volume":"20","author":"WG Goettsch","year":"2006"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: results from a United Kingdom national questionnaire survey","volume":"316","author":"P Kind","year":"1998","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"AY Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"ref19","unstructured":"Department of Health. (2012) NHS Hospital Trust Reference Costs 2010\u201311 http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_131140<\/ext-link> (last accessed 13\/9\/2012)."},{"key":"ref20","unstructured":"NHS Information Centre. (2012) HRG4 2010\/11 Reference Costs Grouper Documentation http:\/\/www.ic.nhs.uk\/services\/the-casemix-service\/using-this-service\/reference\/archived-past-groupers-and-documentation\/costing\/hrg4-2010-11-reference-costs-grouper-documentation<\/ext-link> (last accessed 13\/9\/2012)."},{"key":"ref21","unstructured":"Office for National Statistics. (2011) Annual Survey of Hours and Earnings, 2010 Revised Results http:\/\/www.ons.gov.uk\/ons\/rel\/ashe\/annual-survey-of-hours-and-earnings\/2010-revised-results\/index.html<\/ext-link> (last accessed 13\/9\/2012)."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","article-title":"Analysis of cost data in randomized trials: an application of the non-parametric bootstrap","volume":"19","author":"JA Barber","year":"2000","journal-title":"Stat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hec.903","article-title":"Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions","volume":"13","author":"E Fenwick","year":"2004","journal-title":"Health Economics"},{"key":"ref24","unstructured":"National Institute for Health and Clinical Excellence. (2008) Updated guide to the methods of technology appraisal. http:\/\/www.nice.org.uk\/aboutnice\/howwework\/devnicetech\/guidetothemethodsoftechnologyappraisal.jsp<\/ext-link> (last accessed 13\/9\/2012)."},{"key":"ref25","unstructured":"CREST. (2005) Guidelines on the management of cellulitis in adults. http:\/\/www.gain-ni.org\/Publications\/Guidelines\/Management_Cellulitis_Adults.asp<\/ext-link> (last accessed 13\/9\/2012)."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:01:17Z","timestamp":1565182877000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082694"}},"subtitle":[],"editor":[{"given":"David W.","family":"Dowdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082694","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]}}}